NEW YORK, July 25, 2017 -- Stull, Stull & Brody ("SS&B") announces that a shareholder derivative lawsuit was commenced in the United States District Court for the Eastern District of Pennsylvania against officers and directors of Walter Investment Management Corp. (NYSE:WAC) (“Walter Investment” or the “Company”). If you own the common stock of Walter Investment you may contact Stull, Stull & Brody to discuss your rights.
The shareholder complaint alleges that certain of the Company’s officers and directors breached their fiduciary duties and were unjustly enriched between May 3, 2016 and at least June 22, 2017, and caused substantial harm to the Company. The complaint also alleges that defendants issued false and/or misleading statements and/or failed to disclose that: (a) the Company was involved in fraudulent practices that violated the False Claims Act; (b) the Company’s Ditech subsidiary had a material weakness in its internal controls over financial reporting; and (c) the Company lacked adequate internal controls over financial reporting.
If you have any questions concerning this notice or your rights or interests with respect to these matters, you may contact Stull, Stull & Brody, Attn: Jason D’Agnenica, Esq., at [email protected], or by telephone at 1-212-687-7230 x145.
SS&B has litigated class actions for violations of securities laws and breaches of fiduciary duty on behalf of defrauded investors over the past 40 years and has obtained court approval of substantial settlements on numerous occasions. SS&B has offices in New York and Beverly Hills. SS&B’s website (www.ssbny.com) has additional information about the firm.
Attorney advertising. Prior results do not guarantee a similar outcome. This press release may be considered Attorney advertising in some jurisdictions under applicable laws and ethical rules.


CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Washington Post Publisher Will Lewis Steps Down After Layoffs
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Anta Sports Expands Global Footprint With Strategic Puma Stake 



